Top Story

Stentless bioprosthetic valve effective for patients with congenital heart disease

February 26, 2015

A stentless bioprosthetic valve used to replace the pulmonary valve in patients with congenital heart disease was associated with good clinical outcomes, researchers reported at Cardiology 2015, the 18th Annual Update on Pediatric and Congenital Cardiovascular Disease.

Ben M. Dunne, MB, BCh, BAO, MRCS, and colleagues conducted a retrospective review of  pulmonary valve replacements with the stentless bioprosthetic valve (Freestyle, Medtronic) in 114 patients with congenital heart disease (70 men; mean age, 23.5 years) performed during a 14-year period by a single surgeon, David R. Andrews, FRACS. The researchers contacted patients to determine survival, NYHA class and reintervention, and performed up-to-date echocardiography to assess valve function. Mean clinical follow-up was 71 months; mean echocardiographic follow-up was 61 months.

Constantine D. Mavroudis, MD, MSc Meeting News Coverage

Infants with certain congenital defects, genetic variant show better postsurgical outcomes

February 25, 2015
A minor allele of vascular endothelial growth factor A was associated with improved survival after surgery for congenital heart disease in infants, and the mechanism…
In the Journals

CREDO-Kyoto: Better long-term outcomes with CABG vs. PCI, regardless of diabetes status

February 13, 2015
At 5 years, patients with and without diabetes who had three-vessel and/or left main disease had better rates of cardiac death, MI and coronary revascularization after…
Meeting News Coverage

TAVR improved 1-year outcomes in patients with aortic stenosis, prior CABG

February 6, 2015
Patients with aortic stenosis at increased surgical risk who previously underwent CABG had lower rates of all-cause and mortality at 1 year after treatment with…
CME
Obesity Consults: Volume 2, Number 2 Obesity Forum 2014 Highlights

Obesity Consults: Volume 2, Number 2
Obesity Forum 2014 Highlights

This activity is supported by educational grants from Takeda Pharmaceuticals International, Inc., US Region and Orexigen Therapeutics, Inc; Eisai, Inc.; Novo Nordisk; Vivus, Inc.

Management of obesity is complex, factoring in psychological, environmental, and physiologic causes. Treatment options…
More »
CME
Obesity Consults: Volume 2, Number 4 Obesity and the Cardiovascular System

Obesity Consults: Volume 2, Number 4
Obesity and the Cardiovascular System

This activity is supported by an educational grant from Eisai, Inc. and Vivus, Inc.

Obesity is associated with a wide range of comorbid conditions, including diabetes, hypertension, sleep apnea, and…
More »
Meeting News Coverage

Stentless bioprosthetic valve effective for patients with congenital heart disease

February 26, 2015
A stentless bioprosthetic valve used to replace the pulmonary valve in patients with congenital heart disease was associated with good clinical…
Constantine D. Mavroudis, MD, MSc Meeting News Coverage

Infants with certain congenital defects, genetic variant show better postsurgical outcomes

February 25, 2015
A minor allele of vascular endothelial growth factor A was associated with improved survival after surgery for congenital heart disease in infants…
In the Journals

CREDO-Kyoto: Better long-term outcomes with CABG vs. PCI, regardless of diabetes status

February 13, 2015
At 5 years, patients with and without diabetes who had three-vessel and/or left main disease had better rates of cardiac death, MI and coronary…
Meeting News Coverage

TAVR improved 1-year outcomes in patients with aortic stenosis, prior CABG

February 6, 2015
Patients with aortic stenosis at increased surgical risk who previously underwent CABG had lower rates of all-cause and mortality at 1 year after…
In the Journals

MIDCAB, SES yield similar outcomes in proximal LAD lesions

February 5, 2015
New 7-year data demonstrate similar long-term safety and effectiveness after PCI with sirolimus-eluting stents or minimally invasive direct coronary…
Meeting News Coverage

Blood transfusions during CABG increased risk for pneumonia

January 30, 2015
Patients had a greater risk for developing postoperative pneumonia if they received red blood cell transfusions during or after isolated CABG…
In the Journals

CABG linked to better outcomes than PCI, but at higher price

January 28, 2015
Patients who underwent CABG had improved outcomes at 4 years but at a higher overall cost compared with PCI, according to results of a…
Heart Health: New Guidelines and Improvements

Heart Health: New Guidelines and Improvements

February 9, 2015 Expires: 2/10/2016
Heart disease is the leading cause of death in the United States for men and women, claiming approximately 1 million lives each year. This…
In the Journals

OA increases risk of ischemic heart disease after TKA

January 20, 2015
Following primary total knee arthroplasty, patients with osteoarthritis experienced a long-term risk of ischemic heart disease, according to study…
In the Journals

Outcomes after CABG, DES similar for patients with isolated proximal left anterior descending CAD

January 14, 2015
Patients with isolated proximal left anterior descending CAD who underwent CABG or received drug-eluting stents had similar 3-year rates of…
More Headlines »